Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements

被引:179
作者
Sohlenius-Sternbeck, Anna-Karin [1 ]
机构
[1] AstraZeneca R&D Sodertalje, Res DMPK, SE-15185 Sodertalje, Sweden
关键词
hepatocellularity number; hepatocytes; liver; scaling factors;
D O I
10.1016/j.tiv.2006.06.003
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Biologically based scaling factors have to be used to predict in vivo metabolic clearance of xenobiotics from data obtained in vitro. Although standard values for the hepatocellularity numbers for different species are used in the literature, detailed information on the determination of these values has only been presented for humans and rats, and somewhat different results have been obtained in different studies. The present work was undertaken in order to determine the number of hepatocytes per gram of liver for human, dog, rabbit, rat and mouse livers. Hepatocellularity numbers were calculated from the ratio between the liver protein concentration and the protein concentration in the corresponding hepatocyte suspension. For human, rabbit, rat and mouse livers, the hepatocellular values were in the same range, more precisely 139 +/- 25, 114 +/- 20, 117 +/- 30 and 135 +/- 10 million cells per gram of liver, respectively. However, for the dog liver, the corresponding value was as high as 215 +/- 45 million cells per gram. These values should be of importance during the scaling process of intrinsic clearance for xenobiotics in hepatocytes to in vivo hepatic clearance. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1582 / 1586
页数:5
相关论文
共 12 条
[1]   PREDICTION OF INTRINSIC CLEARANCE OF LOXTIDINE FROM KINETIC-STUDIES IN RAT, DOG AND HUMAN HEPATOCYTES [J].
BAYLISS, MK ;
BELL, JA ;
JENNER, WN ;
WILSON, K .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1990, 18 (06) :1198-1199
[2]   Utility of hepatocytes to model species differences in the metabolism of loxtidine and to predict pharmacokinetic parameters in rat, dog and man [J].
Bayliss, MK ;
Bell, JA ;
Jenner, WN ;
Park, GR ;
Wilson, K .
XENOBIOTICA, 1999, 29 (03) :253-268
[3]  
Bissell D M, 1980, Ann N Y Acad Sci, V349, P85, DOI 10.1111/j.1749-6632.1980.tb29518.x
[4]  
Carlile DJ, 1997, DRUG METAB DISPOS, V25, P903
[5]  
EKINS S, 1995, DRUG METAB DISPOS, V23, P1274
[6]   RELEVANCE OF IN-VITRO KINETIC-PARAMETERS TO IN-VIVO METABOLISM OF XENOBIOTICS [J].
HOUSTON, JB .
TOXICOLOGY IN VITRO, 1994, 8 (04) :507-512
[7]   Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential [J].
Li, AP ;
Lu, C ;
Brent, JA ;
Pham, C ;
Fackett, A ;
Ruegg, CE ;
Silber, PM .
CHEMICO-BIOLOGICAL INTERACTIONS, 1999, 121 (01) :17-35
[8]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[9]   PREPARATION OF RAT-LIVER CELLS .3. ENZYMATIC REQUIREMENTS FOR TISSUE DISPERSION [J].
SEGLEN, PO .
EXPERIMENTAL CELL RESEARCH, 1973, 82 (02) :391-398
[10]   Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver [J].
Wilson, ZE ;
Rostami-Hodjegan, A ;
Burn, JL ;
Tooley, A ;
Boyle, J ;
Ellis, SW ;
Tucker, GT .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) :433-440